Literature DB >> 16937121

Placing quality of life assessments on oncologists' agenda.

Luzia Travado.   

Abstract

Mesh：

Year:  2006        PMID： 16937121     DOI： 10.1007/s00520-006-0130-x

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  15 in total

1.  Practice and policy of measuring quality of life and health economics in cancer clinical trials: a survey among co-operative trial groups.

Authors:  G Kiebert; S Wait; J Bernhard; A Bezjak; D Cella; R Day; J Houghton; C Moinpour; C Scott; R Stephens
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

Review 2.  Assessing the clinical significance of single items relative to summated scores.

Authors:  Jeff A Sloan; Neil Aaronson; Joseph C Cappelleri; Diane L Fairclough; Claudette Varricchio
Journal:  Mayo Clin Proc       Date:  2002-05       Impact factor: 7.616

Review 3.  Assessing meaningful change in quality of life over time: a users' guide for clinicians.

Authors:  Mirjam A G Sprangers; Carol M Moinpour; Timothy J Moynihan; Donald L Patrick; Dennis A Revicki
Journal:  Mayo Clin Proc       Date:  2002-06       Impact factor: 7.616

4.  Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial.

Authors:  Symone B Detmar; Martin J Muller; Jan H Schornagel; Lidwina D V Wever; Neil K Aaronson
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

5.  The MOS short-form general health survey. Reliability and validity in a patient population.

Authors:  A L Stewart; R D Hays; J E Ware
Journal:  Med Care       Date:  1988-07       Impact factor: 2.983

Review 6.  Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores.

Authors:  Marlene H Frost; Amy E Bonomi; Carol Estwing Ferrans; Gilbert Y Wong; Ron D Hays
Journal:  Mayo Clin Proc       Date:  2002-05       Impact factor: 7.616

Review 7.  Methods to explain the clinical significance of health status measures.

Authors:  Gordon H Guyatt; David Osoba; Albert W Wu; Kathleen W Wyrwich; Geoffrey R Norman
Journal:  Mayo Clin Proc       Date:  2002-04       Impact factor: 7.616

8.  The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.

Authors:  D F Cella; D S Tulsky; G Gray; B Sarafian; E Linn; A Bonomi; M Silberman; S B Yellen; P Winicour; J Brannon
Journal:  J Clin Oncol       Date:  1993-03       Impact factor: 44.544

9.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

Review 10.  The clinical significance of quality-of-life results: practical considerations for specific audiences.

Authors:  Tara Symonds; Rick Berzon; Patrick Marquis; Teresa A Rummans
Journal:  Mayo Clin Proc       Date:  2002-06       Impact factor: 7.616
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.